Summary of Ep. 262 Ozempic: Exploring the Benefits and Uses – A Comprehensive Review with Dr. Tracy Gapin:
The current state of metabolic health in the United States has led to a growing interest in GLP-1 agonists, such as semaglutide, Ozempic, Wegovy, and oral Rybelus, which are synthetic peptides. Board-certified urologist and men’s health expert, Dr. Tracy Gapin, has been using these medications to help his patients lose weight and improve body composition. While not a be-all-end-all solution, the GLP-1 agonists can give patients a quick win and kickstart their weight loss journey, motivating them to make further changes. However, it’s important to remember that lifestyle factors such as diet, sleep, and stress management still play a crucial role in achieving and maintaining weight loss. The drugs work by targeting the pancreas and beta cells to increase satiety and reduce gastric emptying. Dr. Gapin cautions that these drugs are not suitable for everyone, and proper hydration and adequate protein intake are important factors to consider when using them.
*****
GLP1 Agonist: Ozempic, Semaglutide, and Wegovy Explained by Dr. Tracy Gapin
Introduction
The current state of metabolic health in the United States and most westernized countries has sparked a great interest in a GLP1 agonist, AKA Semaglutide Ozempic. Cynthia Thurlow, host of the Everyday Wellness Podcast, reconnects with Dr. Tracy Gapin, a board-certified urologist and men’s health expert, to discuss what this drug class represents. This article covers their conversation about Semaglutide, Ozempic, Wegovy, and oral Rybelsus. Current research, side effects, who should not take these medications, and mechanisms of action specific to the pancreas and beta cells, reductions, gastric emptying, and the upregulation of satiety are all covered. They discuss changes in the brain regarding leptin and how these drugs work. They also discuss weight loss resistance and listener questions.
GLP1 Agonist
GLP-1 agonists are synthetic peptides that come in injectable or pill-form that are used in the treatment of type 2 diabetes and obesity. These drugs mimic the effects of a naturally occurring hormone that stimulates the release of insulin from the pancreas in response to food in the intestine. These drugs can help promote weight loss by slowing down the rate at which food leaves the stomach and by decreasing appetite. The following GLP-1 agonists are discussed in the episode:
Semaglutide:Also known as Ozempic, this drug is designed to lower blood sugar levels in people with type 2 diabetes by mimicking the natural hormone incretin. The injection is given once a week and has shown positive weight loss side effects in non-diabetic patients.
Wegovy:This brand-new drug is a higher dosage form of Semaglutide and has been FDA approved for chronic weight management in adults with a BMI of 27 or greater who have at least one weight-related condition. This drug has demonstrated successful weight loss in clinical trials.
Oral Rybelsus:The first oral GLP-1 to be FDA-approved, it is taken once a day, 30 minutes before the first meal of the day. Though it was originally developed as a diabetes medication, it has been found to be effective in promoting weight loss.
Side Effects
Like all medications, these drugs can have side effects, which may include nausea, vomiting, diarrhea, and constipation. Dr. Gapin notes that dehydration can also inhibit weight loss for those taking GLP1 agonists.
Who should not take Semaglutide
Semaglutide is not recommended for people with a personal or family history of an endocrine system condition called multiple endocrine neoplasia.
Weight Loss Resistance
Dr. Gapin stresses the importance of addressing lifestyle changes in conjunction with the medications. These drugs can give patients a kickstart to their weight loss journey but should not be solely relied upon. He notes that adequate protein intake is important, as well as staying hydrated and maintaining consistent metrics to track progress.
Listener Questions Answered
Dr. Gapin answers listener questions about the use of diabetic drugs for non-diabetic patients, whether the drugs target muscle versus fat in terms of weight loss, length of usage, and specific concerns for perimenopausal and menopausal women.
Conclusion
GLP-1 agonists have shown to be effective in promoting weight loss and managing chronic weight gain in adults. Cynthia Thurlow and Dr. Tracy Gapin stress the importance of addressing lifestyle changes in conjunction with the use of these drugs. While it may be tempting to rely solely on medications for weight loss, Dr. Gapin’s approach stresses consistent metrics and lifestyle changes to ensure long-term success. As with any medication, it is important to discuss concerns and suitability with a medical professional.
Comments are closed